GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ribomic Inc (TSE:4591) » Definitions » Minority Interest

Ribomic (TSE:4591) Minority Interest : 円0.00 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Ribomic Minority Interest?

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Ribomic's minority interest for the quarter that ended in Dec. 2023 was 円0.00 Mil.


Ribomic Minority Interest Historical Data

The historical data trend for Ribomic's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ribomic Minority Interest Chart

Ribomic Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Minority Interest
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ribomic Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ribomic Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.


Ribomic (TSE:4591) Business Description

Traded in Other Exchanges
N/A
Address
3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.

Ribomic (TSE:4591) Headlines

No Headlines